Vanguard Group
MCRB icon

Vanguard Group’s Seres Therapeutics MCRB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.25M Sell
292,096
-5,799,903
-95% -$139K ﹤0.01% 3360
2025
Q1
$4.26M Buy
6,091,999
+218,119
+4% +$153K ﹤0.01% 3235
2024
Q4
$4.88M Sell
5,873,880
-186,648
-3% -$155K ﹤0.01% 3282
2024
Q3
$5.73M Sell
6,060,528
-225,221
-4% -$213K ﹤0.01% 3220
2024
Q2
$4.55M Sell
6,285,749
-449,072
-7% -$325K ﹤0.01% 3299
2024
Q1
$5.21M Buy
6,734,821
+729,514
+12% +$565K ﹤0.01% 3287
2023
Q4
$8.41M Buy
6,005,307
+528,563
+10% +$740K ﹤0.01% 3050
2023
Q3
$13M Buy
5,476,744
+119,561
+2% +$285K ﹤0.01% 2725
2023
Q2
$25.7M Sell
5,357,183
-495,953
-8% -$2.38M ﹤0.01% 2486
2023
Q1
$33.2M Sell
5,853,136
-239,801
-4% -$1.36M ﹤0.01% 2367
2022
Q4
$34.1M Sell
6,092,937
-517,919
-8% -$2.9M ﹤0.01% 2360
2022
Q3
$42.4M Buy
6,610,856
+1,280,039
+24% +$8.22M ﹤0.01% 2266
2022
Q2
$18.3M Buy
5,330,817
+263,887
+5% +$905K ﹤0.01% 2681
2022
Q1
$36.1M Buy
5,066,930
+390,665
+8% +$2.78M ﹤0.01% 2464
2021
Q4
$39M Buy
4,676,265
+719,993
+18% +$6M ﹤0.01% 2489
2021
Q3
$27.5M Buy
3,956,272
+550,702
+16% +$3.83M ﹤0.01% 2674
2021
Q2
$81.2M Sell
3,405,570
-13,707
-0.4% -$327K ﹤0.01% 2109
2021
Q1
$70.4M Buy
3,419,277
+251,958
+8% +$5.19M ﹤0.01% 2129
2020
Q4
$77.6M Buy
3,167,319
+411,974
+15% +$10.1M ﹤0.01% 1962
2020
Q3
$78M Buy
2,755,345
+497,366
+22% +$14.1M ﹤0.01% 1805
2020
Q2
$10.7M Buy
2,257,979
+102,823
+5% +$489K ﹤0.01% 2734
2020
Q1
$7.69M Buy
2,155,156
+15,515
+0.7% +$55.4K ﹤0.01% 2739
2019
Q4
$7.38M Buy
2,139,641
+47,355
+2% +$163K ﹤0.01% 2998
2019
Q3
$8.39M Buy
2,092,286
+31,959
+2% +$128K ﹤0.01% 2907
2019
Q2
$6.64M Buy
2,060,327
+1,159,295
+129% +$3.73M ﹤0.01% 3069
2019
Q1
$6.19M Buy
901,032
+50,186
+6% +$345K ﹤0.01% 3059
2018
Q4
$3.85M Sell
850,846
-178,797
-17% -$808K ﹤0.01% 3169
2018
Q3
$7.82M Sell
1,029,643
-386,611
-27% -$2.93M ﹤0.01% 3043
2018
Q2
$12.2M Sell
1,416,254
-299,813
-17% -$2.58M ﹤0.01% 2805
2018
Q1
$12.6M Buy
1,716,067
+161,500
+10% +$1.19M ﹤0.01% 2709
2017
Q4
$15.8M Sell
1,554,567
-108,806
-7% -$1.1M ﹤0.01% 2600
2017
Q3
$26.7M Buy
1,663,373
+78,347
+5% +$1.26M ﹤0.01% 2356
2017
Q2
$17.9M Buy
1,585,026
+19,363
+1% +$219K ﹤0.01% 2505
2017
Q1
$17.6M Buy
1,565,663
+103,456
+7% +$1.17M ﹤0.01% 2489
2016
Q4
$14.5M Buy
1,462,207
+115,013
+9% +$1.14M ﹤0.01% 2569
2016
Q3
$16.6M Buy
1,347,194
+170,270
+14% +$2.09M ﹤0.01% 2440
2016
Q2
$34.2M Buy
1,176,924
+229,970
+24% +$6.68M ﹤0.01% 2074
2016
Q1
$25.2M Buy
946,954
+402,202
+74% +$10.7M ﹤0.01% 2187
2015
Q4
$19.1M Buy
544,752
+64,587
+13% +$2.27M ﹤0.01% 2323
2015
Q3
$14.2M Buy
480,165
+460,165
+2,301% +$13.6M ﹤0.01% 2433
2015
Q2
$830K Buy
+20,000
New +$830K ﹤0.01% 3714